Clinical Trial Update: Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of tasimelteon versus placebo in totally blind individuals with Non-24-Hour Sleep-Wake Disorder; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-24-hour Sleep-wake Disorder

Drugs mentioned

• Tasimelteon (tasimelteon)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Non-24-Hour Sleep-Wake Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-10-16